Clinical Trials Logo

Clinical Trial Summary

The goal of this clinical trial is to test in the Symptoms of Chronic Bronchitis in Chinese Adult Patients with COPD. Participants will be assigned to two sessions of treatments with RheOx - Treatment 1 is scheduled at right lung at the first treatment. - And then approximately one month later, treatment 2 is delivered to left lung at the second treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05641207
Study type Interventional
Source Energenx Medical LTD.
Contact Yang Shaoyu, Master
Phone +86 18910093103
Email Shaoyu.Yang@energenxmedical.com
Status Recruiting
Phase N/A
Start date May 18, 2023
Completion date September 2024

See also
  Status Clinical Trial Phase
Suspended NCT04843345 - Sjogren's Lung Study